Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$305M |
| 2 |
Tesla
TSLA
|
+$304M |
| 3 |
ExxonMobil
XOM
|
+$277M |
| 4 |
Warner Bros
WBD
|
+$263M |
| 5 |
Linde
LIN
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$403M |
| 2 |
CERN
Cerner Corp
CERN
|
+$371M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$310M |
| 4 |
Philip Morris
PM
|
+$254M |
| 5 |
S&P Global
SPGI
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.19% |
| 2 | Healthcare | 14.61% |
| 3 | Financials | 12.06% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
TG Therapeutics
TGTX
$7.46B
| $1.7M | ﹤0.01% |
398,776
-133,278
| -25% | -$832K |
|
2927
Bionano Genomics
BNGO
$13.5M
| $1.7M | ﹤0.01% |
2,048
+384
| +23% | +$395K |
|
|
AGEN
2928
Agenus
AGEN
$329M
| $1.69M | ﹤0.01% |
44,407
+5,293
| +14% | +$192K |
|
2929
Civista Bancshares
CIVB
$593M
| $1.69M | ﹤0.01% |
79,553
-6,435
| -7% | -$139K |
|
|
HTB
2930
HomeTrust Bancshares
HTB
$834M
| $1.69M | ﹤0.01% |
67,469
-7,548
| -10% | -$204K |
|
|
POSH
2931
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $1.69M | ﹤0.01% |
166,840
+150,038
| +893% | +$1.73M |
|
|
AMK
2932
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $1.69M | ﹤0.01% |
89,863
-3,694
| -4% | -$73.9K |
|
|
TSVT
2933
DELISTED
2seventy bio
TSVT
| $1.68M | ﹤0.01% |
127,581
+40,084
| +46% | +$546K |
|
2934
Adicet Bio
ACET
$78.4M
| $1.68M | ﹤0.01% |
7,189
-442
| -6% | -$97.1K |
|
|
NGM
2935
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $1.68M | ﹤0.01% |
130,789
-1,725
| -1% | -$23.9K |
|
2936
Nkarta
NKTX
$167M
| $1.66M | ﹤0.01% |
135,007
+80,902
| +150% | +$1.06M |
|
2937
eGain
EGAN
$206M
| $1.66M | ﹤0.01% |
170,468
-7,222
| -4% | -$72K |
|
2938
Value Line
VALU
$353M
| $1.65M | ﹤0.01% |
25,026
+1,015
| +4% | +$69.6K |
|
2939
AltShares Merger Arbitrage ETF
ARB
$102M
| $1.65M | ﹤0.01% |
63,277
-3,349
| -5% | -$87.7K |
|
2940
MasterCraft Boat Holdings
MCFT
$605M
| $1.65M | ﹤0.01% |
78,421
-4,569
| -6% | -$106K |
|
2941
Home Bancorp
HBCP
$566M
| $1.65M | ﹤0.01% |
48,299
-2,946
| -6% | -$108K |
|
2942
Theravance Biopharma
TBPH
$881M
| $1.65M | ﹤0.01% |
181,915
-7,782
| -4% | -$71.7K |
|
2943
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
$4.88B
| $1.64M | ﹤0.01% |
+39,903
| New | +$1.79M |
|
|
DBD
2944
DELISTED
Diebold Nixdorf Incorporated
DBD
| $1.64M | ﹤0.01% |
720,979
-21,281
| -3% | -$79.3K |
|
2945
Alphatec Holdings
ATEC
$1.51B
| $1.63M | ﹤0.01% |
249,567
+13,350
| +6% | +$123K |
|
2946
iShares Global Tech ETF
IXN
$9.42B
| $1.63M | ﹤0.01% |
35,655
-260,246
| -88% | -$13.1M |
|
|
RDUS
2947
DELISTED
Radius Health, Inc.
RDUS
| $1.62M | ﹤0.01% |
156,680
-8,952
| -5% | -$66.6K |
|
|
ITIC
2948
Investors Title Co
ITIC
$543M
| $1.62M | ﹤0.01% |
10,316
-564
| -5% | -$96.9K |
|
2949
iShares 0-3 Month Treasury Bond ETF
SGOV
$101B
| $1.62M | ﹤0.01% |
+16,166
| New | +$1.62M |
|
2950
Gossamer Bio
GOSS
$75.4M
| $1.61M | ﹤0.01% |
192,890
-35,133
| -15% | -$272K |
|
Similar funds
Bank of New York Mellon's Q2 2022 Portfolio in Review
As of Q2 2022, Bank of New York Mellon held 4,820 positions worth $438B, down 15% from $516B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2022 filing shows 167 new, 1,786 increased, 2,376 reduced and 241 closed positions. Its largest new stake was Hess Midstream: 1,736,004 shares worth $48.6M. The largest sale was Apple, an estimated $403M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2022 buy was Hess Midstream: 1,736,004 shares worth $48.6M.
- Bank of New York Mellon added most to Goldman Sachs in Q2 2022, an estimated $305M increase.
- Bank of New York Mellon's biggest Q2 2022 reduction was Apple, cutting an estimated $403M.
- Bank of New York Mellon fully exited Cerner Corp in Q2 2022, selling an estimated $371M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $438B portfolio in Q2 2022.
- Bank of New York Mellon opened 167 new positions and closed 241 in Q2 2022.
- Bank of New York Mellon's portfolio value fell 15% quarter-over-quarter to $438B.
Based on Bank of New York Mellon's 13F filing for Q2 2022, filed 15 Aug 2022.